Dr. Terry Matkiewicz
Chief Development Officer
Replay available
Matinas Biopharma Holdings, Inc. (AMEX: MTNB) Q2 2023 earnings conference call, held 2023-08-09. Replay captured from the company's public earnings webcast.

Chief Development Officer
Chief Financial Officer
Chief Executive Officer
Analyst, BTIG
Investor Relations, LHA
Watch the replay and follow the connected company analysis, news, and investor updates for Matinas Biopharma Holdings, Inc..
WEBVTT 00:00:00.049 -- 00:00:04.191 Welcome to the Matinas Biopharma second quarter 2023 00:00:04.191 -- 00:00:09.374 financial results conference call. Currently, all participants are in a listen-only mode. 00:00:09.374 -- 00:00:13.396 Following management's prepared remarks, we will hold a question and answer session. 00:00:13.396 -- 00:00:18.079 To ask a question at that time, please press star 1 on your telephone keypad. 00:00:18.079 -- 00:00:23.062 If anyone has difficulty hearing the conference, please press star 0 for operator assistance. 00:00:23.062 -- 00:00:25.683 As a reminder, this conference is being recorded. 00:00:25.683 -- 00:00:28.345 I would now like to turn the conference over to Jody Kane. 00:00:28.345 -- 00:00:30.100 Please go ahead. 00:00:30.100 -- 00:00:35.004 This is Jody Kane with LHA. Thank you for participating in today's call. 00:00:35.004 -- 00:00:40.128 Joining me from Martinez Biopharma are Jerry Jabbour, Chief Executive Officer, 00:00:40.128 -- 00:00:45.292 Dr. Terry Matkiewicz, Chief Development Officer, and Keith Kaczynski, 00:00:45.292 -- 00:00:50.336 Chief Financial Officer. We also have Dr. Terry Ferguson, Chief Medical Officer, 00:00:50.336 -- 00:00:54.100 available to answer questions during the Q&A session. 00:00:54.100 -- 00:00:59.166 I'd like to remind listeners that remarks made During this call, may state 00:00:59.166 -- 00:01:04.549 management's future intentions, hopes, beliefs, expectations, or projections. 00:01:04.549 -- 00:01:08.431 These are forward-looking statements that involve risks and uncertainties. 00:01:08.431 -- 00:01:13.334 Forward-looking statements are made pursuant to the safe harbor provision of the federal 00:01:13.334 -- 00:01:18.097 securities laws. These forward-looking statements are based on Matin...